Tandem Diabetes Care (Nasdaq:TNDM) announced today that the FDA cleared its Tandem Mobi automated insulin delivery (AID) system.
Clearance covers people with diabetes ages six and up, expanding the Tandem portfolio of products.
San Diego-based Tandem says Mobi, which is fully controllable from a mobile app, is the world’s smallest durable AID system.
Mobi features a 200-unit insulin cartridge and an on-pump button to provide an alternative to phone control for insulin boluses. It comes in at less than half the size of the existing Tandem pump system, the t:slim X2 pump.
According to the company, it can fit in a coin pocket, clip to clothing or go on the body with an adhesive sleeve.
Get the full story at our sister site, Drug Delivery Business News.